DB
MDLN

Danske Bank’s Medline Inc MDLN Stock Holding History

Danske Bank’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.84M Buy
+97,400
New +$3.92M 0.01% 549

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
ECU
Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.66% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Danske Bank's MDLN Position: Q2 2026 in Review

Danske Bank opened a new position in Medline Inc (MDLN) in Q2 2026: 97,400 shares worth $3.84M. The stake represents 0.01% of the portfolio and ranks #549 among its holdings.

310 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Danske Bank held 97,400 shares of Medline Inc worth $3.84M as of Q2 2026.
  • Medline Inc was a new Danske Bank position in Q2 2026.
  • Medline Inc made up 0.01% of Danske Bank's portfolio in Q2 2026, its #549 holding.
  • 310 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.